4.0 Review

Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency - Three consecutive cases and review of the literature

Related references

Note: Only part of the references are listed.
Article Oncology

Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma

Zachary Wright et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)

Letter Allergy

Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City

Hsi-en Ho et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Article Surgery

Outcomes of COVID-19 in hospitalized solid organ transplant recipients compared to a matched cohort of non-transplant patients at a national healthcare system in the United States

Arielle M. Fisher et al.

Summary: This study compared the clinical outcomes of SOT recipients with COVID-19 to non-SOT recipients during hospitalization, finding that SOT recipients had higher mortality rates and were more likely to require mechanical ventilation, develop acute kidney injury, and receive vasopressor support during hospitalization.

CLINICAL TRANSPLANTATION (2021)

Article Gastroenterology & Hepatology

Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study

Luca S. Belli et al.

Summary: Despite concerns, data from adult liver transplant recipients with COVID-19 infection in Europe shows that age over 70, diabetes, and chronic kidney disease are associated with increased risk of death, while the use of tacrolimus may improve survival rates in these patients.

GASTROENTEROLOGY (2021)

Review Medicine, Research & Experimental

An integrative look at SARS-CoV-2 (Review)

Miguel A. Ortega et al.

Summary: SARS-CoV-2, the etiological agent of COVID-19 pandemic, shows higher infectivity and mortality compared to previous coronaviruses. Its aggressive nature stems from its ability to easily infect and spread through interaction with human ACE-2 receptor. The diverse patient responses highlight the importance of immune system function, with overactive responses potentially leading to severe cases. Developing therapies and vaccines to regulate immune response will be crucial in managing clinical outcomes and reducing transmission of the virus.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Article Allergy

COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

Adrian M. Shields et al.

Summary: Patients with PID and symptomatic SID have higher morbidity and mortality risks from COVID-19 compared to the general population, requiring enhanced protective measures.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Medicine, General & Internal

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

R. Libster et al.

Summary: A randomized, double-blind, placebo-controlled trial of convalescent plasma with high IgG titers against SARS-CoV-2 in older adult patients within 72 hours after the onset of mild Covid-19 symptoms found that early administration of high-titer convalescent plasma reduced the progression of Covid-19 in mildly ill infected older adults.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

M. J. Joyner et al.

Summary: This study found that higher anti-SARS-CoV-2 IgG antibody levels in convalescent plasma were associated with a lower risk of death among patients hospitalized with Covid-19 who were not receiving mechanical ventilation. The association between antibody levels and mortality risk was moderated by mechanical ventilation status, with no significant effect seen in patients who had already received ventilation.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Immunology

COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature

Mohammed A. Raja et al.

Summary: A systematic review and meta-analysis of SOT recipients with SARS-CoV-2 infection revealed a high hospital admission rate and mortality rate. Common symptoms included fever and cough, with the majority of recipients requiring hospital treatment. Use of immunosuppressive medications decreased, while treatments varied.

TRANSPLANTATION REVIEWS (2021)

Article Immunology

Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium

Sapna A. Mehta et al.

Summary: Among kidney and liver transplant recipients with HIV, there was a 4% incidence rate of COVID-19 with high mortality. Most patients required hospitalization and aggressive treatment with high-dose steroids, tocilizumab, remdesivir, and convalescent plasma.

TRANSPLANTATION (2021)

Article Cell & Tissue Engineering

Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient

Tali-Anne Szwebel et al.

Summary: A HIV-1-infected patient with chronic COVID-19 was treated with anti-CD20 monoclonal antibody for B-cell lymphoma, but the treatment's viral efficacy was confirmed to be poor through monitoring plasma SARS-CoV-2 RNA by ddPCR. The patient's complete recovery after COVID-19 convalescent plasmatherapy was closely associated with clearance of plasma SARS-CoV-2 RNA.

STEM CELL REVIEWS AND REPORTS (2021)

Letter Biophysics

COVID-19 outcomes in patients with hematologic disease

Florent Malard et al.

BONE MARROW TRANSPLANTATION (2020)

Letter Hematology

Clinical outcome of coronavirus disease 2019 in haemato-oncology patients

James A. Aries et al.

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Editorial Material Medicine, Research & Experimental

Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19

Christopher J. Morabito et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)

Editorial Material Allergy

Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients-a perspective

Lennart Hammarstrom et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Review Virology

Convalescent plasma transfusion for the treatment of COVID-19: Systematic review

Karthick Rajendran et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Editorial Material Hematology

COVID-19 convalescent plasma: phase 2

C. Michael Knudson et al.

TRANSFUSION (2020)

Editorial Material Hematology

COVID-19 Convalescent Plasma: Now Is the Time for Better Science

Sunny Dzik

TRANSFUSION MEDICINE REVIEWS (2020)

Editorial Material Clinical Neurology

Mild COVID-19 infection despite chronic B cell depletion in a patient with aquaporin-4-positive neuromyelitis optica spectrum disorder

Marina A. Creed et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Article Biochemistry & Molecular Biology

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

Mingfeng Liao et al.

NATURE MEDICINE (2020)

Editorial Material Urology & Nephrology

COVID-19: implications for immunosuppression in kidney disease and transplantation

Andreas Kronbichler et al.

NATURE REVIEWS NEPHROLOGY (2020)

Article Allergy

Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover

Annarosa Soresina et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2020)

Article Surgery

In-depth virological assessment of kidney transplant recipients with COVID-19

Ilies Benotmane et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Article Hematology

Janus-faced course of COVID-19 infection in patients with hematological malignancies

Rosa Bellmann-Weiler et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2020)

Article Hematology

Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies

Jose Maria Sanchez-Pina et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2020)

Letter Allergy

Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma

Estefania Mira et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)

Article Immunology

A fatal case of coronavirus disease 2019 in a patient with common variable immunodeficiency

Jyotsna Mullur et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2020)

Article Medicine, General & Internal

Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients

Michael J. Joyner et al.

MAYO CLINIC PROCEEDINGS (2020)

Article Hematology

First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia

Magdalena Figlerowicz et al.

TRANSFUSION AND APHERESIS SCIENCE (2020)

Article Hematology

Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma

Ayse Karatas et al.

TRANSFUSION AND APHERESIS SCIENCE (2020)

Review Hematology

International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection

Michael Murphy et al.

TRANSFUSION MEDICINE REVIEWS (2020)

Letter Oncology

Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia

Guido Lancman et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Letter Allergy

Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma

Haoli Jin et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)

Review Multidisciplinary Sciences

Antibody response to SARS-CoV-2 infection in humans: A systematic review

Nathan Post et al.

PLOS ONE (2020)

Article Pharmacology & Pharmacy

Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities

Jonathan D. Geiger et al.

FRONTIERS IN PHARMACOLOGY (2020)

Article Immunology

HCoV- and SARS-CoV-2 Cross-Reactive T Cells in CVID Patients

Sophie Steiner et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Ania Wajnberg et al.

SCIENCE (2020)

Letter Medicine, General & Internal

Is there relationship between SARS-CoV-2 and the complement C3 and C4?

Hamad Dheir et al.

TURKISH JOURNAL OF MEDICAL SCIENCES (2020)

Article Medicine, General & Internal

Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia

Sara Barmettler et al.

JAMA NETWORK OPEN (2018)

Article Rheumatology

Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response

R. M. Thurlings et al.

ANNALS OF THE RHEUMATIC DISEASES (2008)

Review Surgery

Rituximab, an anti-CD20 monoclonal antibody: History and mechanism of action

MD Pescovitz

AMERICAN JOURNAL OF TRANSPLANTATION (2006)